SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 11,592.89 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 4,211.00 |
| Book Value / Share | 35.68 |
| Price / Book | n/a |
| NCAV ($M) | 942.10 |
| NCAV / Share | 7.98 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.09 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.29 |
| Current Ratio | 2.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,501.10 |
| Assets | 5,770.00 |
| Liabilities | 1,559.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3,979.90 |
| Operating Income | 614.70 |
| Net Income | 432.20 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 667.30 |
| Cash from Investing | -359.80 |
| Cash from Financing | -212.60 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| BLFE – BioLife Sciences Inc. | BLMS – Bloomios, Inc. |
| BMMJ – Body and Mind Inc. | BOIRF – Boiron SA |
| BPTH – Bio-Path Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io